olmesartan has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aki, K; Arai, T; Fujita, E; Fukuda, Y; Fukunaga, Y; Ishikawa, A; Kuwahara, N; Masuda, Y; Mii, A; Natori, Y; Shimizu, A | 1 |
1 other study(ies) available for olmesartan and Anti-Glomerular Basement Membrane Disease
Article | Year |
---|---|
ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Anti-Glomerular Basement Membrane Disease; Blood Pressure; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Imidazoles; Inflammation; Kidney Glomerulus; Macrophages; Male; Rats; Rats, Inbred WKY; Tetrazoles | 2010 |